Literature DB >> 11580302

Immunological approaches to the treatment of spinal cord injury.

M Schwartz1.   

Abstract

The innate and adaptive arms of the immune system, represented principally by macrophages and by T and B cells, respectively, provide body tissues with mechanisms of defence, protection and repair. In the central nervous system (CNS), probably because of its status of 'immune privilege', any immune activity has long been viewed as detrimental. Recent studies have provided evidence, however, that immune activity after traumatic CNS injury may have a beneficial effect, manifested by promotion of regeneration and reduction in the secondary degeneration of neurons that escaped direct injury. Rigorous regulation of immune system activity allows the individual to derive the benefit of such neuroprotection without the risk of detrimental side effects. Recently, our research group found a way to boost the T-cell-mediated autoimmune protection while avoiding the risk of autoimmune disease.

Entities:  

Mesh:

Year:  2001        PMID: 11580302     DOI: 10.2165/00063030-200115090-00003

Source DB:  PubMed          Journal:  BioDrugs        ISSN: 1173-8804            Impact factor:   5.807


  4 in total

1.  Multiple channel bridges for spinal cord injury: cellular characterization of host response.

Authors:  Yang Yang; Laura De Laporte; Marina L Zelivyanskaya; Kevin J Whittlesey; Aileen J Anderson; Brian J Cummings; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

2.  The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury.

Authors:  Laura E Gonzalez-Lara; Xiaoyun Xu; Klara Hofstetrova; Anna Pniak; Yuhua Chen; Catherine D McFadden; Francisco M Martinez-Santiesteban; Brian K Rutt; Arthur Brown; Paula J Foster
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

3.  Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury.

Authors:  Hannah M Tuinstra; Misael O Aviles; Seungjin Shin; Samantha J Holland; Marina L Zelivyanskaya; Alan G Fast; Sarah Y Ko; Daniel J Margul; Anne K Bartels; Ryan M Boehler; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Biomaterials       Date:  2011-11-29       Impact factor: 12.479

4.  Treatment of spinal cord injury with co-grafts of genetically modified Schwann cells and fetal spinal cord cell suspension in the rat.

Authors:  Shi-Qing Feng; Xiao-Hong Kong; Shi-Fu Guo; Pei Wang; Li Li; Jin-Hua Zhong; Xin-Fu Zhou
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.